Patent · US Active

Crystal form as ASK1 inhibitor and preparation method and application thereof

US11814382B2 · kind B2 · utility

0Cited by

0References

16Claims

0Family size

Assignee

FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD. · CN

Inventors

Shengbin Zhang · Nanhu, CN
Ning Li · New Canaan, US
Tao Yu · Shanghai, CN
Yusheng Fu · Shanghai, CN
Jiahu Wu · Shanghai, CN
Chengde Wu · Shanghai, CN

Key dates

Filing date	Jul 19, 2019
Grant date	Nov 14, 2023
Priority date	—
Expiry date	Feb 6, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided are crystal forms A, B, C and D of a compound of formula (I), and application of the crystal forms in the preparation of drugs for treating ASK1-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.